11.38 USD
↗ 0.02 (0.18%)PRE MARKET (AS OF 07:31 PM EDT)
Keros Therapeutics, Inc. Common Stock
KROSNASDAQ • USD
Market: OPEN
KROS is currently priced at $11.38. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place KROS at a fair price relative to peers.
Technical & fundamental data as of Oct 2, 2026.
Open?$11.38
High?$11.43
Low?$11.02
Prev. Close?$11.36
Volume?199.9K
Avg. Volume?181.9K
VWAP?$11.28
Rel. Volume?1.10x
Bid / Ask
Bid?$9.64 × 100
Ask?$13.07 × 100
Spread?$3.43
Midpoint?$11.36
Valuation & Ratios
Market Cap?225.2M
Shares Out?19.8M
Float?18.4M
Float %?93.1%
P/E Ratio?N/A
P/B Ratio?0.86
EPS?-$4.19
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
Employees
92
Market Cap
225.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-04-08
Address
1050 WALTHAM STREET, SUITE 302
LEXINGTON, MA 02421
Phone: 617-314-6297
LEXINGTON, MA 02421
Phone: 617-314-6297
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?61
Momentum?10
Short Sent.?24
Piotroski F-Score?0/9Weak
Altman Z-Score?2.70Grey
Confidence?51%Low
Short InterestHigh
Short % of Float?7.29%Elevated
Short Interest?1.3M
Days to Cover?9.1
Free Float18.4M
Avg Daily Volume147.1K
Settlement Date2026-09-15
Financial Health
Current Ratio?21.96Strong
Quick Ratio?21.96Strong
Cash Ratio?21.20Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?0.86CHEAP▾
Peers100
S&P97
P/S?15.00HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?0.3CHEAP▾
Peers100
S&P97
EV/Sales?-2.16CHEAP▾
S&P97
Returns & Efficiency
ROE?-31.7%WEAK▾
S&P6
ROA?-28.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-48487000
Enterprise Value?$-32369144
Fundamentals ratios updated end of day